brd2 (Proteintech)
Structured Review
Brd2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+brd2/BRD2+Antibody/pm42766962-298-59-61
Average 93 stars, based on 22 article reviews
Images
Related Articles
Labeling:Article Title: Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. Article Snippet: .. Polyvinylidene difluoride membranes were labeled with anti–caspase-3 (Cell Signaling), anti-TYRO3 (Cell Signaling), anti-GFP (GeneTex), anti–MMP-2 (GeneTex), anti-lamin A/C (GeneTex), anti-BRD3 (Proteintech, Abnova), other:Article Title: BRD4-mediated transcriptional activation of PDLIM4 enhances p21 stability and chemosensitivity in lung adenocarcinoma independent of p53 Article Snippet: Primary antibodies which included anti-GAPDH (Cat. No. 60004–1-1 g), anti-BRD2 (Cat. No. 22236–1-AP), anti-BRD3 (Cat. No. 11859–1-AP), anti-BRD4 (Cat. No. 67374–2-1 g), anti-TUBULIN (Cat. No. 10094–1-AP), anti-FLAG (Cat. No. 66008–4-Ig), anti-HA (Cat. No. 51064–2-AP), anti-GFP (Cat. No. 50430–2-AP), and Article Title: BRD4-mediated transcriptional activation of PDLIM4 enhances p21 stability and chemosensitivity in lung adenocarcinoma independent of p53. Article Snippet: Primary antibodies included anti-GAPDH (Cat No.60004-1-1g), anti-BRD2(Cat No.22236-1-AP), anti-BRD3 (Cat No.11859-1AP), anti-BRD4(Cat No.67374-2-1g), anti-TUBULIN (Cat No.10094-1-AP), antiFLAG (Cat No.66008-4-Ig), anti-HA (Cat No.51064-2-AP), anti-GFP (Cat No.504302-AP) and anti-P21( Article Title: Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 Article Snippet: Anti-SPOP antibody (16750-1-AP), Anti-BRD2 (22236-1-AP) and Chromatin Immunoprecipitation:Article Title: Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation. Article Snippet: Proteolysis targeting chimeras (PROTACs) hijack E3 ligases and the ubiquitin–proteasome system to achieve selective degradation of neo-substrates.. Their ability to target otherwise intractable substrates has rendered them a valuable modality in drug discovery.. However, only a handful of over 600 human E3 ligases have been functionalized for PROTAC applications. Flow Cytometry:Article Title: Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation. Article Snippet: Proteolysis targeting chimeras (PROTACs) hijack E3 ligases and the ubiquitin–proteasome system to achieve selective degradation of neo-substrates.. Their ability to target otherwise intractable substrates has rendered them a valuable modality in drug discovery.. However, only a handful of over 600 human E3 ligases have been functionalized for PROTAC applications. Magnetic Resonance Imaging:Article Title: Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation. Article Snippet: Proteolysis targeting chimeras (PROTACs) hijack E3 ligases and the ubiquitin–proteasome system to achieve selective degradation of neo-substrates.. Their ability to target otherwise intractable substrates has rendered them a valuable modality in drug discovery.. However, only a handful of over 600 human E3 ligases have been functionalized for PROTAC applications. Incubation:Article Title: Apabetalone alleviates ligature-induced periodontitis by inhibiting M1 macrophage polarization via an immunometabolic shift. Article Snippet: Objectives: To explore the effects and biological mechanism of apabetalone on periodontal inflammation by regulating glycolysis and metabolites.. Methods: A ligature-induced periodontitis model was established in mice and apabetalone was administered on the ligation silk for two weeks.. Inflammation levels and alveolar bone absorption were explored using microcomputed tomography and histopathological analysis. Blocking Assay:Article Title: Apabetalone alleviates ligature-induced periodontitis by inhibiting M1 macrophage polarization via an immunometabolic shift. Article Snippet: Objectives: To explore the effects and biological mechanism of apabetalone on periodontal inflammation by regulating glycolysis and metabolites.. Methods: A ligature-induced periodontitis model was established in mice and apabetalone was administered on the ligation silk for two weeks.. Inflammation levels and alveolar bone absorption were explored using microcomputed tomography and histopathological analysis. |
